Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Malou C Vermeulen"'
Autor:
Jolien M.R. Van der Meer, Paul K.J.D. de Jonge, Anniek B. van der Waart, Alexander C. Geerlings, Jurgen P. Moonen, Jolanda Brummelman, Janne de Klein, Malou C. Vermeulen, Ralph J.A. Maas, Nicolaas P.M. Schaap, Janneke S. Hoogstad-van Evert, Petronella B. Ottevanger, Joop H. Jansen, Willemijn Hobo, Harry Dolstra
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Combining natural killer (NK) cell adoptive transfer with tumor-sensitizing chemotherapy is an attractive approach against recurrent ovarian cancer (OC), as OC is sensitive to NK cell-mediated immunity. Previously, we showed that CD34+ hematopoietic
Externí odkaz:
https://doaj.org/article/619acac2e57b40f7a452e2426b67db92
Autor:
Jolien M R, Van der Meer, Paul K J D, de Jonge, Anniek B, van der Waart, Alexander C, Geerlings, Jurgen P, Moonen, Jolanda, Brummelman, Janne, de Klein, Malou C, Vermeulen, Ralph J A, Maas, Nicolaas P M, Schaap, Janneke S, Hoogstad-van Evert, Petronella B, Ottevanger, Joop H, Jansen, Willemijn, Hobo, Harry, Dolstra
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Combining natural killer (NK) cell adoptive transfer with tumor-sensitizing chemotherapy is an attractive approach against recurrent ovarian cancer (OC), as OC is sensitive to NK cell-mediated immunity. Previously, we showed that CD34+ hematopoietic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8084d4ef7b24a39f4dd64b66352196fe
https://pubmed.ncbi.nlm.nih.gov/34616589
https://pubmed.ncbi.nlm.nih.gov/34616589
Autor:
Janne de Klein, Paul K J D de Jonge, Willemijn Hobo, Nicolaas Schaap, Jurgen P Moonen, Alexander C Geerlings, Janneke S. Hoogstad-van Evert, Jolien M R van der Meer, Harry Dolstra, Anniek B. van der Waart, Malou C Vermeulen, Joop H. Jansen, Jolanda Brummelman, Petronella B. Ottevanger, Ralph J. A. Maas
Publikováno v:
Oncoimmunology, 10
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology, 10, 1
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology, 10, 1
Combining natural killer (NK) cell adoptive transfer with tumor-sensitizing chemotherapy is an attractive approach against recurrent ovarian cancer (OC), as OC is sensitive to NK cell-mediated immunity. Previously, we showed that CD34+ hematopoietic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74eea731f41c6fa24b7ca31f8a8e92fd
https://doi.org/10.1080/2162402x.2021.1981049
https://doi.org/10.1080/2162402x.2021.1981049